Novo Nordisk
NVO
#25
Rank
โ‚ฌ349.78 B
Marketcap
81,77ย โ‚ฌ
Share price
-17.83%
Change (1 day)
-12.23%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2024 (TTM): โ‚ฌ16.30 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚ฌ39.69 Billion. In 2023 the company made an earning of โ‚ฌ14.84 Billion, an increase over its 2022 earnings that were of โ‚ฌ9.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚ฌ16.30 B9.86%
2023 โ‚ฌ14.84 B57.64%
2022 โ‚ฌ9.41 B5.35%
2021 โ‚ฌ8.93 B12.47%
2020 โ‚ฌ7.94 B13.07%
2019 โ‚ฌ7.02 B-3.35%
2018 โ‚ฌ7.27 B1.79%
2017 โ‚ฌ7.14 B4.52%
2016 โ‚ฌ6.83 B9.42%
2015 โ‚ฌ6.24 B8.24%
2014 โ‚ฌ5.77 B3.45%
2013 โ‚ฌ5.57 B19.02%
2012 โ‚ฌ4.68 B15.21%
2011 โ‚ฌ4.06 B17.71%
2010 โ‚ฌ3.45 B24.78%
2009 โ‚ฌ2.76 B10.62%
2008 โ‚ฌ2.50 B55.97%
2007 โ‚ฌ1.60 B7.07%
2006 โ‚ฌ1.49 B18.18%
2005 โ‚ฌ1.26 B11.33%
2004 โ‚ฌ1.13 B
2002 โ‚ฌ0.70 B-14.39%
2001 โ‚ฌ0.82 B-52.82%
2000 โ‚ฌ1.74 B250%
1999 โ‚ฌ0.49 B31.21%
1998 โ‚ฌ0.37 B34.31%
1997 โ‚ฌ0.28 B11.46%
1996 โ‚ฌ0.25 B9.03%
1995 โ‚ฌ0.23 B-3.15%
1994 โ‚ฌ0.23 B-0.67%
1993 โ‚ฌ0.24 B45.38%
1992 โ‚ฌ0.16 B-13.81%
1991 โ‚ฌ0.19 B37.12%
1990 โ‚ฌ0.14 B-0.79%
1989 โ‚ฌ0.14 B26.2%
1988 โ‚ฌ0.11 B24.97%
1987 โ‚ฌ89.79 M-0.9%
1986 โ‚ฌ90.61 M-7.78%
1985 โ‚ฌ98.26 M24.87%
1984 โ‚ฌ78.69 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ6.67 B-61.09%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.76 B-43.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ6.62 Billion-138.56%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ7.12 B-58.48%๐Ÿ‡ซ๐Ÿ‡ท France